Top compounds associated with response to TCERG1L


Feature Type Standardized
Nominal ANOVA
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.31 3e-14
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 1e-11
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.23 5e-11
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.21 8e-10
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA PX-12 CTRPv2 pan-cancer AAC 0.16 2e-08
Download CSV